Report Details

Pharma & Healthcare

Global Retinal Disorders Therapy Market Insights and Forecast to 2028

ID: XI87079 | Published: May 2022 | Pages: 112 | Format: PDF | Industry: Pharma & Healthcare

Description

ToC

Companies

Speak with Analyst

Retinal Disorders Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Retinal Disorders Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Retinal Disorders Therapy Market Segment by Type
Age Related Macular Degeneration
Diabetic Retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole

Retinal Disorders Therapy Market Segment by Application
Hospitals
Clinics
Others

Retinal Disorders Therapy Market by Company
ALLERGAN
AbbVie
Alimera Sciences
Janssen Biotech
Swedish Orphan Biovitrum
Roche
Bristol-Myers Squibb
Genzyme
Genentech
OCULAR THERAPEUTIX
Bausch & Lomb
UCBCares
Aier Eye Hospital
Alcon Holdings, Inc.
Eyebright Medical
Kanghong Pharmaceutical
Huaxia Eye Hospital
Xingqi Pharmaceutical

Retinal Disorders Therapy Market Analysis by Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

FAQ

The Retinal Disorders Therapy market research report includes specific segments by region (country), i.e. North America, Europe, Asia Pacific, South America, Middle East and Africa

The Retinal Disorders Therapy market report provides global companies with an opportunity to enter new markets, invest in new sectors, analyze consumer reactions, investigate global competition, and ultimately make smart investments.

Retinal Disorders Therapy report covers the latest market developments in terms of acquisitions, growth strategies, joint ventures and collaborations, new product launches, and more on industry.

We can provide customization on reports prior to the sale. If you need customization we request you to provide specific details on customization prior to the dispatch. This is because we move fast with your queries as it requires a lot of diligence. There will be additional charges for customization once the report is dispatched to you and will be treated as post-sales query.

Requesting a Sample copy of the report from Xcellent Insights is hassle-free! You can either request it from the report page or call our sales Executive at US: +1 408 627 7717 /UK: +44 208 638 6439 and share/discuss your requirements. Our Team will share the sample copy of the report with you within 12 Working Hours / Shortly.

Ordering a report from Xcellent Insights is hassle-free! You can select a licence type that suits your requirement and proceed to checkout. It will redirect you to the payment gateway with a list of payment options. Be rest assured that we do not store the payment details. Once we receive the payment, a confirmation email will be sent on your registered mail id with details on the report delivery timeline. You can also get your order placed through our business development executives and they will guide you thoroughly.

  • You should buy this report from Xcellent Insights for a better clarity on market scenarios.
  • The market report has been prepared using a pragmatic approach to suit your needs.
  • We have an extensive library of reports that can help you understand the market landscape and make informed decisions about your business.
  • Additionally, the reports are written by experienced analysts who have a deep understanding of the market and the latest trends.
  • Besides, customization is a value-added service if you decide to opt.

Table of Content
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinal Disorders Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Age Related Macular Degeneration
1.2.3 Diabetic Retinopathy
1.2.4 Ocular Inflammatory Disease (Uveitis)
1.2.5 Macular Hole
1.3 Market by Application
1.3.1 Global Retinal Disorders Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Retinal Disorders Therapy Market Perspective (2017-2028)
2.2 Retinal Disorders Therapy Growth Trends by Region
2.2.1 Retinal Disorders Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Retinal Disorders Therapy Historic Market Size by Region (2017-2022)
2.2.3 Retinal Disorders Therapy Forecasted Market Size by Region (2023-2028)
2.3 Retinal Disorders Therapy Market Dynamics
2.3.1 Retinal Disorders Therapy Industry Trends
2.3.2 Retinal Disorders Therapy Market Drivers
2.3.3 Retinal Disorders Therapy Market Challenges
2.3.4 Retinal Disorders Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retinal Disorders Therapy Players by Revenue
3.1.1 Global Top Retinal Disorders Therapy Players by Revenue (2017-2022)
3.1.2 Global Retinal Disorders Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Retinal Disorders Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Retinal Disorders Therapy Revenue
3.4 Global Retinal Disorders Therapy Market Concentration Ratio
3.4.1 Global Retinal Disorders Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinal Disorders Therapy Revenue in 2021
3.5 Retinal Disorders Therapy Key Players Head office and Area Served
3.6 Key Players Retinal Disorders Therapy Product Solution and Service
3.7 Date of Enter into Retinal Disorders Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Retinal Disorders Therapy Breakdown Data by Type
4.1 Global Retinal Disorders Therapy Historic Market Size by Type (2017-2022)
4.2 Global Retinal Disorders Therapy Forecasted Market Size by Type (2023-2028)
5 Retinal Disorders Therapy Breakdown Data by Application
5.1 Global Retinal Disorders Therapy Historic Market Size by Application (2017-2022)
5.2 Global Retinal Disorders Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Retinal Disorders Therapy Market Size (2017-2028)
6.2 North America Retinal Disorders Therapy Market Size by Type
6.2.1 North America Retinal Disorders Therapy Market Size by Type (2017-2022)
6.2.2 North America Retinal Disorders Therapy Market Size by Type (2023-2028)
6.2.3 North America Retinal Disorders Therapy Market Share by Type (2017-2028)
6.3 North America Retinal Disorders Therapy Market Size by Application
6.3.1 North America Retinal Disorders Therapy Market Size by Application (2017-2022)
6.3.2 North America Retinal Disorders Therapy Market Size by Application (2023-2028)
6.3.3 North America Retinal Disorders Therapy Market Share by Application (2017-2028)
6.4 North America Retinal Disorders Therapy Market Size by Country
6.4.1 North America Retinal Disorders Therapy Market Size by Country (2017-2022)
6.4.2 North America Retinal Disorders Therapy Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Retinal Disorders Therapy Market Size (2017-2028)
7.2 Europe Retinal Disorders Therapy Market Size by Type
7.2.1 Europe Retinal Disorders Therapy Market Size by Type (2017-2022)
7.2.2 Europe Retinal Disorders Therapy Market Size by Type (2023-2028)
7.2.3 Europe Retinal Disorders Therapy Market Share by Type (2017-2028)
7.3 Europe Retinal Disorders Therapy Market Size by Application
7.3.1 Europe Retinal Disorders Therapy Market Size by Application (2017-2022)
7.3.2 Europe Retinal Disorders Therapy Market Size by Application (2023-2028)
7.3.3 Europe Retinal Disorders Therapy Market Share by Application (2017-2028)
7.4 Europe Retinal Disorders Therapy Market Size by Country
7.4.1 Europe Retinal Disorders Therapy Market Size by Country (2017-2022)
7.4.2 Europe Retinal Disorders Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Retinal Disorders Therapy Market Size (2017-2028)
8.2 Asia-Pacific Retinal Disorders Therapy Market Size by Type
8.2.1 Asia-Pacific Retinal Disorders Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Retinal Disorders Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Retinal Disorders Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Retinal Disorders Therapy Market Size by Application
8.3.1 Asia-Pacific Retinal Disorders Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Retinal Disorders Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Retinal Disorders Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Retinal Disorders Therapy Market Size by Region
8.4.1 Asia-Pacific Retinal Disorders Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Retinal Disorders Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Retinal Disorders Therapy Market Size (2017-2028)
9.2 Latin America Retinal Disorders Therapy Market Size by Type
9.2.1 Latin America Retinal Disorders Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Retinal Disorders Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Retinal Disorders Therapy Market Share by Type (2017-2028)
9.3 Latin America Retinal Disorders Therapy Market Size by Application
9.3.1 Latin America Retinal Disorders Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Retinal Disorders Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Retinal Disorders Therapy Market Share by Application (2017-2028)
9.4 Latin America Retinal Disorders Therapy Market Size by Country
9.4.1 Latin America Retinal Disorders Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Retinal Disorders Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retinal Disorders Therapy Market Size (2017-2028)
10.2 Middle East & Africa Retinal Disorders Therapy Market Size by Type
10.2.1 Middle East & Africa Retinal Disorders Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Retinal Disorders Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Retinal Disorders Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Retinal Disorders Therapy Market Size by Application
10.3.1 Middle East & Africa Retinal Disorders Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Retinal Disorders Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Retinal Disorders Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Retinal Disorders Therapy Market Size by Country
10.4.1 Middle East & Africa Retinal Disorders Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Retinal Disorders Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 ALLERGAN
11.1.1 ALLERGAN Company Details
11.1.2 ALLERGAN Business Overview
11.1.3 ALLERGAN Retinal Disorders Therapy Introduction
11.1.4 ALLERGAN Revenue in Retinal Disorders Therapy Business (2017-2022)
11.1.5 ALLERGAN Recent Developments
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Retinal Disorders Therapy Introduction
11.2.4 AbbVie Revenue in Retinal Disorders Therapy Business (2017-2022)
11.2.5 AbbVie Recent Developments
11.3 Alimera Sciences
11.3.1 Alimera Sciences Company Details
11.3.2 Alimera Sciences Business Overview
11.3.3 Alimera Sciences Retinal Disorders Therapy Introduction
11.3.4 Alimera Sciences Revenue in Retinal Disorders Therapy Business (2017-2022)
11.3.5 Alimera Sciences Recent Developments
11.4 Janssen Biotech
11.4.1 Janssen Biotech Company Details
11.4.2 Janssen Biotech Business Overview
11.4.3 Janssen Biotech Retinal Disorders Therapy Introduction
11.4.4 Janssen Biotech Revenue in Retinal Disorders Therapy Business (2017-2022)
11.4.5 Janssen Biotech Recent Developments
11.5 Swedish Orphan Biovitrum
11.5.1 Swedish Orphan Biovitrum Company Details
11.5.2 Swedish Orphan Biovitrum Business Overview
11.5.3 Swedish Orphan Biovitrum Retinal Disorders Therapy Introduction
11.5.4 Swedish Orphan Biovitrum Revenue in Retinal Disorders Therapy Business (2017-2022)
11.5.5 Swedish Orphan Biovitrum Recent Developments
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Retinal Disorders Therapy Introduction
11.6.4 Roche Revenue in Retinal Disorders Therapy Business (2017-2022)
11.6.5 Roche Recent Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Retinal Disorders Therapy Introduction
11.7.4 Bristol-Myers Squibb Revenue in Retinal Disorders Therapy Business (2017-2022)
11.7.5 Bristol-Myers Squibb Recent Developments
11.8 Genzyme
11.8.1 Genzyme Company Details
11.8.2 Genzyme Business Overview
11.8.3 Genzyme Retinal Disorders Therapy Introduction
11.8.4 Genzyme Revenue in Retinal Disorders Therapy Business (2017-2022)
11.8.5 Genzyme Recent Developments
11.9 Genentech
11.9.1 Genentech Company Details
11.9.2 Genentech Business Overview
11.9.3 Genentech Retinal Disorders Therapy Introduction
11.9.4 Genentech Revenue in Retinal Disorders Therapy Business (2017-2022)
11.9.5 Genentech Recent Developments
11.10 OCULAR THERAPEUTIX
11.10.1 OCULAR THERAPEUTIX Company Details
11.10.2 OCULAR THERAPEUTIX Business Overview
11.10.3 OCULAR THERAPEUTIX Retinal Disorders Therapy Introduction
11.10.4 OCULAR THERAPEUTIX Revenue in Retinal Disorders Therapy Business (2017-2022)
11.10.5 OCULAR THERAPEUTIX Recent Developments
11.11 Bausch & Lomb
11.11.1 Bausch & Lomb Company Details
11.11.2 Bausch & Lomb Business Overview
11.11.3 Bausch & Lomb Retinal Disorders Therapy Introduction
11.11.4 Bausch & Lomb Revenue in Retinal Disorders Therapy Business (2017-2022)
11.11.5 Bausch & Lomb Recent Developments
11.12 UCBCares
11.12.1 UCBCares Company Details
11.12.2 UCBCares Business Overview
11.12.3 UCBCares Retinal Disorders Therapy Introduction
11.12.4 UCBCares Revenue in Retinal Disorders Therapy Business (2017-2022)
11.12.5 UCBCares Recent Developments
11.13 Aier Eye Hospital
11.13.1 Aier Eye Hospital Company Details
11.13.2 Aier Eye Hospital Business Overview
11.13.3 Aier Eye Hospital Retinal Disorders Therapy Introduction
11.13.4 Aier Eye Hospital Revenue in Retinal Disorders Therapy Business (2017-2022)
11.13.5 Aier Eye Hospital Recent Developments
11.14 Alcon Holdings, Inc.
11.14.1 Alcon Holdings, Inc. Company Details
11.14.2 Alcon Holdings, Inc. Business Overview
11.14.3 Alcon Holdings, Inc. Retinal Disorders Therapy Introduction
11.14.4 Alcon Holdings, Inc. Revenue in Retinal Disorders Therapy Business (2017-2022)
11.14.5 Alcon Holdings, Inc. Recent Developments
11.15 Eyebright Medical
11.15.1 Eyebright Medical Company Details
11.15.2 Eyebright Medical Business Overview
11.15.3 Eyebright Medical Retinal Disorders Therapy Introduction
11.15.4 Eyebright Medical Revenue in Retinal Disorders Therapy Business (2017-2022)
11.15.5 Eyebright Medical Recent Developments
11.16 Kanghong Pharmaceutical
11.16.1 Kanghong Pharmaceutical Company Details
11.16.2 Kanghong Pharmaceutical Business Overview
11.16.3 Kanghong Pharmaceutical Retinal Disorders Therapy Introduction
11.16.4 Kanghong Pharmaceutical Revenue in Retinal Disorders Therapy Business (2017-2022)
11.16.5 Kanghong Pharmaceutical Recent Developments
11.17 Huaxia Eye Hospital
11.17.1 Huaxia Eye Hospital Company Details
11.17.2 Huaxia Eye Hospital Business Overview
11.17.3 Huaxia Eye Hospital Retinal Disorders Therapy Introduction
11.17.4 Huaxia Eye Hospital Revenue in Retinal Disorders Therapy Business (2017-2022)
11.17.5 Huaxia Eye Hospital Recent Developments
11.18 Xingqi Pharmaceutical
11.18.1 Xingqi Pharmaceutical Company Details
11.18.2 Xingqi Pharmaceutical Business Overview
11.18.3 Xingqi Pharmaceutical Retinal Disorders Therapy Introduction
11.18.4 Xingqi Pharmaceutical Revenue in Retinal Disorders Therapy Business (2017-2022)
11.18.5 Xingqi Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

Tables and Figures
List of Tables
Table 1. Global Retinal Disorders Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Age Related Macular Degeneration
Table 3. Key Players of Diabetic Retinopathy
Table 4. Key Players of Ocular Inflammatory Disease (Uveitis)
Table 5. Key Players of Macular Hole
Table 6. Global Retinal Disorders Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Retinal Disorders Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Retinal Disorders Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Retinal Disorders Therapy Market Share by Region (2017-2022)
Table 10. Global Retinal Disorders Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Retinal Disorders Therapy Market Share by Region (2023-2028)
Table 12. Retinal Disorders Therapy Market Trends
Table 13. Retinal Disorders Therapy Market Drivers
Table 14. Retinal Disorders Therapy Market Challenges
Table 15. Retinal Disorders Therapy Market Restraints
Table 16. Global Retinal Disorders Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Retinal Disorders Therapy Revenue Share by Players (2017-2022)
Table 18. Global Top Retinal Disorders Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Disorders Therapy as of 2021)
Table 19. Ranking of Global Top Retinal Disorders Therapy Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Retinal Disorders Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Retinal Disorders Therapy Product Solution and Service
Table 23. Date of Enter into Retinal Disorders Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Retinal Disorders Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Retinal Disorders Therapy Revenue Market Share by Type (2017-2022)
Table 27. Global Retinal Disorders Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Retinal Disorders Therapy Revenue Market Share by Type (2023-2028)
Table 29. Global Retinal Disorders Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Retinal Disorders Therapy Revenue Share by Application (2017-2022)
Table 31. Global Retinal Disorders Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Retinal Disorders Therapy Revenue Share by Application (2023-2028)
Table 33. North America Retinal Disorders Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Retinal Disorders Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Retinal Disorders Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Retinal Disorders Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Retinal Disorders Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Retinal Disorders Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Retinal Disorders Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Retinal Disorders Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Retinal Disorders Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Retinal Disorders Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Retinal Disorders Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Retinal Disorders Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Retinal Disorders Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Retinal Disorders Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Retinal Disorders Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Retinal Disorders Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Retinal Disorders Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Retinal Disorders Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Retinal Disorders Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Retinal Disorders Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Retinal Disorders Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Retinal Disorders Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Retinal Disorders Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Retinal Disorders Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Retinal Disorders Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Retinal Disorders Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Retinal Disorders Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Retinal Disorders Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Retinal Disorders Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Retinal Disorders Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 63. ALLERGAN Company Details
Table 64. ALLERGAN Business Overview
Table 65. ALLERGAN Retinal Disorders Therapy Product
Table 66. ALLERGAN Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
Table 67. ALLERGAN Recent Developments
Table 68. AbbVie Company Details
Table 69. AbbVie Business Overview
Table 70. AbbVie Retinal Disorders Therapy Product
Table 71. AbbVie Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
Table 72. AbbVie Recent Developments
Table 73. Alimera Sciences Company Details
Table 74. Alimera Sciences Business Overview
Table 75. Alimera Sciences Retinal Disorders Therapy Product
Table 76. Alimera Sciences Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
Table 77. Alimera Sciences Recent Developments
Table 78. Janssen Biotech Company Details
Table 79. Janssen Biotech Business Overview
Table 80. Janssen Biotech Retinal Disorders Therapy Product
Table 81. Janssen Biotech Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
Table 82. Janssen Biotech Recent Developments
Table 83. Swedish Orphan Biovitrum Company Details
Table 84. Swedish Orphan Biovitrum Business Overview
Table 85. Swedish Orphan Biovitrum Retinal Disorders Therapy Product
Table 86. Swedish Orphan Biovitrum Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
Table 87. Swedish Orphan Biovitrum Recent Developments
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche Retinal Disorders Therapy Product
Table 91. Roche Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
Table 92. Roche Recent Developments
Table 93. Bristol-Myers Squibb Company Details
Table 94. Bristol-Myers Squibb Business Overview
Table 95. Bristol-Myers Squibb Retinal Disorders Therapy Product
Table 96. Bristol-Myers Squibb Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
Table 97. Bristol-Myers Squibb Recent Developments
Table 98. Genzyme Company Details
Table 99. Genzyme Business Overview
Table 100. Genzyme Retinal Disorders Therapy Product
Table 101. Genzyme Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
Table 102. Genzyme Recent Developments
Table 103. Genentech Company Details
Table 104. Genentech Business Overview
Table 105. Genentech Retinal Disorders Therapy Product
Table 106. Genentech Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
Table 107. Genentech Recent Developments
Table 108. OCULAR THERAPEUTIX Company Details
Table 109. OCULAR THERAPEUTIX Business Overview
Table 110. OCULAR THERAPEUTIX Retinal Disorders Therapy Product
Table 111. OCULAR THERAPEUTIX Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
Table 112. OCULAR THERAPEUTIX Recent Developments
Table 113. Bausch & Lomb Company Details
Table 114. Bausch & Lomb Business Overview
Table 115. Bausch & Lomb Retinal Disorders Therapy Product
Table 116. Bausch & Lomb Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
Table 117. Bausch & Lomb Recent Developments
Table 118. UCBCares Company Details
Table 119. UCBCares Business Overview
Table 120. UCBCares Retinal Disorders Therapy Product
Table 121. UCBCares Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
Table 122. UCBCares Recent Developments
Table 123. Aier Eye Hospital Company Details
Table 124. Aier Eye Hospital Business Overview
Table 125. Aier Eye Hospital Retinal Disorders Therapy Product
Table 126. Aier Eye Hospital Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
Table 127. Aier Eye Hospital Recent Developments
Table 128. Alcon Holdings, Inc. Company Details
Table 129. Alcon Holdings, Inc. Business Overview
Table 130. Alcon Holdings, Inc. Retinal Disorders Therapy Product
Table 131. Alcon Holdings, Inc. Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
Table 132. Alcon Holdings, Inc. Recent Developments
Table 133. Eyebright Medical Company Details
Table 134. Eyebright Medical Business Overview
Table 135. Eyebright Medical Retinal Disorders Therapy Product
Table 136. Eyebright Medical Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
Table 137. Eyebright Medical Recent Developments
Table 138. Kanghong Pharmaceutical Company Details
Table 139. Kanghong Pharmaceutical Business Overview
Table 140. Kanghong Pharmaceutical Retinal Disorders Therapy Product
Table 141. Kanghong Pharmaceutical Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
Table 142. Kanghong Pharmaceutical Recent Developments
Table 143. Huaxia Eye Hospital Company Details
Table 144. Huaxia Eye Hospital Business Overview
Table 145. Huaxia Eye Hospital Retinal Disorders Therapy Product
Table 146. Huaxia Eye Hospital Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
Table 147. Huaxia Eye Hospital Recent Developments
Table 148. Xingqi Pharmaceutical Company Details
Table 149. Xingqi Pharmaceutical Business Overview
Table 150. Xingqi Pharmaceutical Retinal Disorders Therapy Product
Table 151. Xingqi Pharmaceutical Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
Table 152. Xingqi Pharmaceutical Recent Developments
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Disorders Therapy Market Share by Type: 2021 VS 2028
Figure 2. Age Related Macular Degeneration Features
Figure 3. Diabetic Retinopathy Features
Figure 4. Ocular Inflammatory Disease (Uveitis) Features
Figure 5. Macular Hole Features
Figure 6. Global Retinal Disorders Therapy Market Share by Application: 2021 VS 2028
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Retinal Disorders Therapy Report Years Considered
Figure 11. Global Retinal Disorders Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Retinal Disorders Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Retinal Disorders Therapy Market Share by Region: 2021 VS 2028
Figure 14. Global Retinal Disorders Therapy Market Share by Players in 2021
Figure 15. Global Top Retinal Disorders Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Disorders Therapy as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Retinal Disorders Therapy Revenue in 2021
Figure 17. North America Retinal Disorders Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Retinal Disorders Therapy Market Size Market Share by Type (2017-2028)
Figure 19. North America Retinal Disorders Therapy Market Size Market Share by Application (2017-2028)
Figure 20. North America Retinal Disorders Therapy Market Size Share by Country (2017-2028)
Figure 21. United States Retinal Disorders Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Retinal Disorders Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Retinal Disorders Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Retinal Disorders Therapy Market Size Market Share by Type (2017-2028)
Figure 25. Europe Retinal Disorders Therapy Market Size Market Share by Application (2017-2028)
Figure 26. Europe Retinal Disorders Therapy Market Size Share by Country (2017-2028)
Figure 27. Germany Retinal Disorders Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Retinal Disorders Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Retinal Disorders Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Retinal Disorders Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Retinal Disorders Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Retinal Disorders Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Retinal Disorders Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Retinal Disorders Therapy Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Retinal Disorders Therapy Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Retinal Disorders Therapy Market Size Share by Region (2017-2028)
Figure 37. China Retinal Disorders Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Retinal Disorders Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Retinal Disorders Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Retinal Disorders Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Retinal Disorders Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Retinal Disorders Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Retinal Disorders Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Retinal Disorders Therapy Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Retinal Disorders Therapy Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Retinal Disorders Therapy Market Size Share by Country (2017-2028)
Figure 47. Mexico Retinal Disorders Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Retinal Disorders Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Retinal Disorders Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Retinal Disorders Therapy Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Retinal Disorders Therapy Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Retinal Disorders Therapy Market Size Share by Country (2017-2028)
Figure 53. Turkey Retinal Disorders Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Retinal Disorders Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Retinal Disorders Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. ALLERGAN Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
Figure 57. AbbVie Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
Figure 58. Alimera Sciences Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
Figure 59. Janssen Biotech Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
Figure 60. Swedish Orphan Biovitrum Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
Figure 61. Roche Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
Figure 63. Genzyme Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
Figure 64. Genentech Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
Figure 65. OCULAR THERAPEUTIX Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
Figure 66. Bausch & Lomb Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
Figure 67. UCBCares Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
Figure 68. Aier Eye Hospital Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
Figure 69. Alcon Holdings, Inc. Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
Figure 70. Eyebright Medical Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
Figure 71. Kanghong Pharmaceutical Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
Figure 72. Huaxia Eye Hospital Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
Figure 73. Xingqi Pharmaceutical Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Key Players
ALLERGAN
AbbVie
Alimera Sciences
Janssen Biotech
Swedish Orphan Biovitrum
Roche
Bristol-Myers Squibb
Genzyme
Genentech
OCULAR THERAPEUTIX
Bausch & Lomb
UCBCares
Aier Eye Hospital
Alcon Holdings, Inc.
Eyebright Medical
Kanghong Pharmaceutical
Huaxia Eye Hospital
Xingqi Pharmaceutical

Speak With Analyst

Request Free PDF Sample
Pre-Order Enquiry
Check Today's Discount

$3260 $1999
$4760 $2999
$6260 $3999
$1560 $1099

Why Choose Us

  • Extensive Library of Reports.
  • Identify the clients' needs.
  • Pragmatic Research Approach.
  • Clarity on Market Scenarios.
  • Tailor-Made Solutions.
  • Expert Analysts Team.
  • Competitive and Fair Prices.

Clientele